{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:19:21Z","timestamp":1787771961788,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adverse drug reactions (ADRs) are major problems in the drug therapy. Cutaneous adverse drug reactions (CADRs) are the most common ADRs. The pattern of CADRs differs among various drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To record various morphological patterns of CADRs and their causal relationships among patients attending in a tertiary care centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>An observational, cross-sectional, clinical study was conducted for a duration of one and a half years in a tertiary care centre in eastern India. Patients presenting with suspected CADRs were included if drug identity could be ascertained. Clinical profiling and drug history were recorded, and causality assessment was carried out as per the Naranjo scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>The commonest CADR in our study was fixed drug eruption (FDE) 48.61%, followed by SJS-TEN spectrum 16.66%, maculopapular rash 11.11% and so on. Severe cutaneous adverse drug reactions (SCARs) such as SJS, TEN, SJS-TEN Overlap, AGEP and DRESS accounted for 18 cases (25%). The most common culprit drugs were antimicrobials (54.16%), followed by nonsteroidal anti-inflammatory drugs (15.27%) and anticonvulsants (12.5%). Most of the CADRs were in probable category.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The pattern of CADRs and the drugs causing them in our study population are similar to some previous studies but somewhat different from most of the previous Indian studies. The incidence of SCARs was significantly higher than in previous other studies in India and abroad.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_944_20","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T07:02:04Z","timestamp":1709103724000},"page":"106-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India"],"prefix":"10.4103","volume":"69","author":[{"given":"Sujata","family":"Sinha","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinamy","family":"Kar","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Das","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Dutta","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"De","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions:Definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0378-6323.38431","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Raksha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/0253-7613.28212","article-title":"Adverse cutaneous drug reactions:A one year survey at a dermatology outpatient clinic of a tertiary care hospital","volume":"38","author":"Chatterjee","year":"2006","journal-title":"Indian J Pharmacol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4103\/0378-6323.191134","article-title":"Guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis:An Indian perspective","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/jhg.2013.37","article-title":"Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury","volume":"58","author":"Kaniwa","year":"2013","journal-title":"J Hum Genet"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0253-7613.106441","article-title":"Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India","volume":"45","author":"Naveen","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.14260\/jemds\/2016\/674","article-title":"Study of pattern of antibiotic induced adverse cutaneous drug reactions in a tertiary care hospital","volume":"5","author":"Patel","year":"2016","journal-title":"J Evol Med Dent Sci"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/2229-5178.156384","article-title":"A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India","volume":"6","author":"Sharma","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2229-516X.81982","article-title":"Cutaneous adverse drug reactions in a tertiary care teaching hospital:A North Indian perspective","volume":"1","author":"Nandha","year":"2011","journal-title":"Int J Appl Basic Med Res"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0019-5154.105279","article-title":"Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur","volume":"58","author":"Hiware","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R11-20240829","first-page":"21","article-title":"Epidemiological study of cutaneous adverse drug reactions:In Oman","volume":"23","author":"Al-Raaie","year":"2008","journal-title":"Oman Med J"},{"key":"R12-20240829","first-page":"20","article-title":"Adverse cutaneous drug reactions:Clinical pattern and causative agents in a tertiary care center in South India","volume":"70","author":"Pudukadan","year":"2004","journal-title":"Indian J Dermatol Venereal Leprol"},{"key":"R13-20240829","first-page":"223","article-title":"Cutaneous drug reactions:Clinical types and causative agents. A five-year survey of inss-patients (1981-1985)","volume":"69","author":"Alanko","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/2229-5178.146165","article-title":"Cutaneous adverse drug reactions in Indian population:A systematic review","volume":"5","author":"Patel","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"R15-20240829","first-page":"e41116","article-title":"Association of acetaminophen with Stevens-Johnson syndrome and toxic epidermal necrolysis:Pharmacologic considerations and treatment options","volume":"15","author":"Spillers","year":"2023","journal-title":"Cureus"},{"key":"R16-20240829","first-page":"11","article-title":"Adverse cutaneous drug reactions to Anticonvulsants \u2013A study at a tertiary care center in Telangana","volume":"15","author":"Sudharani","year":"2016","journal-title":"IOSR J Dent Med Sci"},{"key":"R17-20240829","first-page":"292","article-title":"Cutaneous adverse drug reactions in hospitalized patients in a tertiary care centre","volume":"36","author":"Noel","year":"2004","journal-title":"Indian J Pharmacol"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug induced cutaneous reactions. A report from Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"R19-20240829","first-page":"2229","article-title":"A study of adverse cutaneous drug reactions in outdoor patients attending to Skin and V. D. Department of Shree Krishna Hospital, Karamsad","volume":"2","author":"Suthar","year":"2011","journal-title":"Int J Res Pharm Biomed Sci"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/ijcp.12026","article-title":"E Ernst Adverse effects of homeopathy:A systematic review of published case reports and case series","volume":"66","author":"Posadzki 1","year":"2012","journal-title":"Int J Clin Pract"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_944_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:22:39Z","timestamp":1787768559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_944_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_944_20","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2020-10-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}